Dr. Signorovitch is committed to using data science to accelerate progress for families living with Duchenne muscular dystrophy. His work centers on transforming complex data into practical solutions that improve patient outcomes, expand access to care, and inform policies that matter to the Duchenne community. He brings extensive experience in natural history studies, clinical trial design, regulatory strategy and in health economics and policy analysis. His expertise also includes predictive analytics and personalized medicine to tailor interventions to individual needs, as well as collaborative research platforms that bring patients, clinicians, and advocates together in shared decision-making. Dr. Signorovitch’s work has influenced regulators and payers worldwide, appeared in leading scientific journals, and been presented at major scientific and policy conferences.
